Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy.
作者信息
Li Lianbo
机构信息
Departments of Radiation Oncology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States.
出版信息
Front Cell Dev Biol. 2022 Aug 16;10:971477. doi: 10.3389/fcell.2022.971477. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy.社论：肺癌化疗中的耐药性与个体化化疗
Front Cell Dev Biol. 2022 Aug 16;10:971477. doi: 10.3389/fcell.2022.971477. eCollection 2022.
2
Mechanisms of resistance to chemotherapy in non-small cell lung cancer.非小细胞肺癌化疗耐药的机制。
Arch Pharm Res. 2021 Feb;44(2):146-164. doi: 10.1007/s12272-021-01312-y. Epub 2021 Feb 19.
3
Chemotherapy remains an essential element of personalized care for persons with lung cancers.化疗仍然是肺癌患者个性化治疗的重要组成部分。
Ann Oncol. 2016 Oct;27(10):1829-35. doi: 10.1093/annonc/mdw271. Epub 2016 Jul 25.
4
Chemotherapy for Lung Cancer in the Era of Personalized Medicine.个性化医疗时代的肺癌化疗
Tuberc Respir Dis (Seoul). 2019 Jul;82(3):179-189. doi: 10.4046/trd.2018.0068. Epub 2018 Dec 20.
5
Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer.机制探索：电压依赖性钙通道α2δ1 亚基介导的小细胞肺癌肿瘤干细胞标志物与化疗耐药的关系。
Clin Cancer Res. 2018 May 1;24(9):2148-2158. doi: 10.1158/1078-0432.CCR-17-1932. Epub 2018 Feb 6.
6
Personalized chemotherapy of lung cancer: What the radiologist should know.肺癌的个体化化疗：放射科医生应该知道什么。
Diagn Interv Imaging. 2016 Mar;97(3):287-96. doi: 10.1016/j.diii.2015.11.013. Epub 2016 Feb 5.
7
Creating chemotherapeutic-resistant breast cancer cell lines: advances and future perspectives.创建化疗耐药性乳腺癌细胞系：进展与未来展望。
Future Oncol. 2016 Jun;12(12):1517-27. doi: 10.2217/fon-2016-0059. Epub 2016 Apr 11.
8
Prevalence of in vitro extreme chemotherapy resistance in resected nonsmall-cell lung cancer.切除的非小细胞肺癌体外极端化疗耐药的发生率
Ann Thorac Surg. 2006 Feb;81(2):440-6; discussion 446-7. doi: 10.1016/j.athoracsur.2005.08.037.
9
Novel insights into the role of microRNA in lung cancer resistance to treatment and targeted therapy.关于微小RNA在肺癌治疗耐药性和靶向治疗中作用的新见解。
Curr Cancer Drug Targets. 2014;14(3):241-58. doi: 10.2174/1568009614666140305104845.
10
Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance.解析复发急性髓系白血病患者化疗耐药的分子机制：迈向克服耐药性的精准医学。
Cancer Cell Int. 2021 Jan 14;21(1):53. doi: 10.1186/s12935-021-01746-w.
引用本文的文献
1
Immunomodulatory effects of BAFF and APRIL cytokines in post-pulmonary infection lung cancer: Implications for drug resistance and progression.BAFF 和 APRIL 细胞因子在后肺部感染肺癌中的免疫调节作用：对耐药性和进展的影响。
Saudi Med J. 2024 Mar;45(3):223-229. doi: 10.15537/smj.2024.45.3.20230873.
Zotero 插件